← All stocks

Tenaya Therapeutics, Inc.

TNYA Net selling
CIK 0001858848 #4093 in the set updated 18 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$5.98M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$5.98M
35 of 35 sales
Net
−$5.98M
−$5.98M against sales at will

By person

6 insiders · 35 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
COLUMN GROUP III GP, LP entity
10% owner
$5.93M (12)
−$5.93M
0
$0.00
Ali Faraz
Chief Executive Officer
$32.18K (9)
−$32.18K
539,782
$383.14K
+186.6%
Tingley Whittemore
Chief Medical Officer
$14.89K (9)
−$14.89K
263,073
$186.73K
+106.1%
Higa Tomohiro
SVP, Finance
$5.23K (5)
−$5.23K
118,267
$83.95K
+15.8%
GOEDDEL DAVID V
Director
49,313,559
$35.00M
+262.6%
Saito Chihiro
SVP, Accounting and Fin. Ops.
60,983
$43.29K
−3.6%

No percentages here. This company's share count has moved by a factor of 2.8 over the window, from 79,220,516 to 224,230,012 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 35
Transactions with no price 0
Shares from compensation/vesting 407,600
History held since 4 Aug 2021